The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine

Hematological Oncology
Yuriko Nishiyama-FujitaYoshinobu Aisa

Abstract

No abstract listed.

References

Oct 8, 2005·The American Journal of Clinical Nutrition·Olivier BouillanneChristian Aussel
Jun 15, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Bhumika ShahClarie B Hollenbeck
Jan 8, 2008·The American Journal of Clinical Nutrition·Kohsuke YamadaHiromichi Kumagai

❮ Previous
Next ❯

Citations

Feb 2, 2021·Future Oncology·Hailong TangGuangxun Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.